Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 279

    1.

    Normalization of hyperhomocysteinemia with L-thyroxine in hypothyroidism.

    Hussein WI, Green R, Jacobsen DW, Faiman C.

    Ann Intern Med. 1999 Sep 7;131(5):348-51.PMID: 10475887 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Is subclinical hypothyroidism associated with hyperhomocysteinemia?

    Aldasouqi S, Nkansa-Dwamena D, Bokhari S, Alzahrani AS, Khan M, Al-Reffi A, Merdad A.

    Endocr Pract. 2004 Sep-Oct;10(5):399-403.PMID: 15760786 [PubMed - indexed for MEDLINE]Related articles

    3.

    Homocysteine concentrations in subclinical hypothyroidism.

    Sengül E, Cetinarslan B, Tarkun I, Cantürk Z, Türemen E.

    Endocr Res. 2004 Aug;30(3):351-9.PMID: 15554351 [PubMed - indexed for MEDLINE]Related articles

    4.

    Determinants of changes in plasma homocysteine in hyperthyroidism and hypothyroidism.

    Diekman MJ, van der Put NM, Blom HJ, Tijssen JG, Wiersinga WM.

    Clin Endocrinol (Oxf). 2001 Feb;54(2):197-204.PMID: 11207634 [PubMed - indexed for MEDLINE]Related articles

    5.

    Homocysteine: a risk factor for cardiovascular disease in subclinical hypothyroidism?

    Deicher R, Vierhapper H.

    Thyroid. 2002 Aug;12(8):733-6.PMID: 12225643 [PubMed - indexed for MEDLINE]Related articles

    6.

    Prospective blinded study of the relationship between plasma homocysteine and progression of symptomatic peripheral arterial disease.

    Taylor LM Jr, Moneta GL, Sexton GJ, Schuff RA, Porter JM.

    J Vasc Surg. 1999 Jan;29(1):8-19; discussion 19-21.PMID: 9925456 [PubMed - indexed for MEDLINE]Related articles

    7.

    Homocysteine, hypothyroidism, and effect of thyroid hormone replacement.

    Catargi B, Parrot-Roulaud F, Cochet C, Ducassou D, Roger P, Tabarin A.

    Thyroid. 1999 Dec;9(12):1163-6.PMID: 10646653 [PubMed - indexed for MEDLINE]Related articles

    8.

    Homocysteine, folate and cobalamin levels in hypothyroid women before and after treatment.

    Orzechowska-Pawilojc A, Sworczak K, Lewczuk A, Babinska A.

    Endocr J. 2007 Jun;54(3):471-6. Epub 2007 Apr 27.PMID: 17464093 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Endothelial dysfunction in patients with peripheral arterial disease and chronic hyperhomocysteinemia: potential role of ADMA.

    Sydow K, Hornig B, Arakawa N, Bode-Böger SM, Tsikas D, Münzel T, Böger RH.

    Vasc Med. 2004 May;9(2):93-101.PMID: 15521698 [PubMed - indexed for MEDLINE]Related articles

    10.

    Mild hyperhomocysteinemia is not associated with cardiac allograft coronary disease.

    Giannetti N, Herity NA, Alimollah A, Gao SZ, Schroeder JS, Yeung AC, Hunt SA, Valantine HA.

    Clin Transplant. 2001 Aug;15(4):247-52.PMID: 11683818 [PubMed - indexed for MEDLINE]Related articles

    11.

    Elevated plasma homocysteine level is an independent predictor of coronary heart disease events in patients with type 2 diabetes mellitus.

    Soinio M, Marniemi J, Laakso M, Lehto S, Rönnemaa T.

    Ann Intern Med. 2004 Jan 20;140(2):94-100.PMID: 14734331 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Homocysteine and cystatin C level changes in haemodialysed patients and connection with cerebro- and cardiovascular complications.

    Locsey L, Szegedi J, Dán A, Görögh S, Tóths E.

    Acta Physiol Hung. 2001;88(3-4):293-9.PMID: 12162587 [PubMed - indexed for MEDLINE]Related articles

    13.

    Plasma total homocysteine levels in hyperthyroid and hypothyroid patients.

    Nedrebø BG, Ericsson UB, Nygård O, Refsum H, Ueland PM, Aakvaag A, Aanderud S, Lien EA.

    Metabolism. 1998 Jan;47(1):89-93.PMID: 9440483 [PubMed - indexed for MEDLINE]Related articles

    14.

    Risk factors for cardiovascular disease in women with subclinical hypothyroidism.

    Luboshitzky R, Aviv A, Herer P, Lavie L.

    Thyroid. 2002 May;12(5):421-5.PMID: 12097204 [PubMed - indexed for MEDLINE]Related articles

    16.

    Hyperhomocysteinemia and retinal vascular occlusive disease.

    Abu El-Asrar AM, Abdel Gader AG, Al-Amro SA, Al-Attas OS.

    Eur J Ophthalmol. 2002 Nov-Dec;12(6):495-500.PMID: 12510718 [PubMed - indexed for MEDLINE]Related articles

    17.

    Hyperhomocysteinemia: a risk factor for retinal vein occlusion.

    Yildirim C, Yaylali V, Tatlipinar S, Kaptanoğlu B, Akpinar S.

    Ophthalmologica. 2004 Mar-Apr;218(2):102-6.PMID: 15004498 [PubMed - indexed for MEDLINE]Related articles

    18.

    Thyrotropin suppression by thyroid hormone replacement is correlated with thyroxine level normalization in central hypothyroidism.

    Shimon I, Cohen O, Lubetsky A, Olchovsky D.

    Thyroid. 2002 Sep;12(9):823-7.PMID: 12481949 [PubMed - indexed for MEDLINE]Related articles

    19.

    The effects of thyroxine replacement on the levels of serum asymmetric dimethylarginine (ADMA) and other biochemical cardiovascular risk markers in patients with subclinical hypothyroidism.

    Ozcan O, Cakir E, Yaman H, Akgul EO, Erturk K, Beyhan Z, Bilgi C, Erbil MK.

    Clin Endocrinol (Oxf). 2005 Aug;63(2):203-6.PMID: 16060915 [PubMed - indexed for MEDLINE]Related articles

    20.

    Which thyroid-stimulating hormone level should be sought in hypothyroid patients under L-thyroxine replacement therapy?

    Gursoy A, Ozduman Cin M, Kamel N, Gullu S.

    Int J Clin Pract. 2006 Jun;60(6):655-9.PMID: 16805747 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data